DGX vs LH
Quest Diagnostics (DGX) and Labcorp (LH) compared side by side. Quest Diagnostics (DGX) is larger, with a market cap of $26.7B versus $26.7B for Labcorp, about 1.0 times the size. On trailing earnings, DGX is cheaper at 24.1x versus 27.2x for LH.
Head to head
| Metric | DGX | LH |
|---|---|---|
| Market cap | $26.7B | $26.7B |
| P/E (TTM) | 24.1x | 27.2x |
| Forward P/E | 20.2x | 16.6x |
| Revenue (TTM) | $11.8B | $14.3B |
| Revenue growth | 10.0% | 5.8% |
| Gross margin | 33.2% | 28.9% |
| Operating margin | 15.6% | 12.2% |
| Free cash flow | $1.3B | $1.2B |
| Dividend yield | 1.42% | 0.88% |
| 1-year return | +34.2% | +17.0% |
| 5-year return (annual) | +12.7% | +7.4% |
| Max drawdown | -49% | -96% |
| FI Handbook grade | C+ | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
DGX vs LH FAQ
Which is bigger, DGX or LH?
Quest Diagnostics (DGX) is larger, with a market cap of $26.7B versus $26.7B for Labcorp, about 1.0 times the size.
Is DGX or LH cheaper?
On trailing earnings, DGX is cheaper at 24.1x versus 27.2x for LH. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, DGX or LH?
DGX returned +34.2% over the past year including dividends, versus +17.0% for LH, through October 23, 2026.
Which pays a higher dividend, DGX or LH?
DGX yields 1.42% versus 0.88% for LH.
Full pages: Quest Diagnostics · Labcorp